相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cannabidiol Elevates Mechanistic Target of Rapamycin Inhibitor Levels in Patients With Tuberous Sclerosis Complex
Daniel Ebrahimi-Fakhari et al.
PEDIATRIC NEUROLOGY (2020)
Everolimus for epilepsy and autism spectrum disorder in tuberous sclerosis complex: EXIST-3 substudy in Japan
Masashi Mizuguchi et al.
BRAIN & DEVELOPMENT (2019)
Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2 years of age - a multicenter retrospective study
Afshin Saffari et al.
ORPHANET JOURNAL OF RARE DISEASES (2019)
Use of Cardiac MRI to Assess Antitumor Efficacy of Everolimus in Sporadic Cardiac Rhabdomyoma
Kyle A. Davis et al.
PEDIATRICS (2019)
A randomized controlled trial with everolimus for IQ and autism in tuberous sclerosis complex
Iris E. Overwater et al.
NEUROLOGY (2019)
Cannabidiol Interacts Significantly with Everolimus-Report of a Patient with Tuberous Sclerosis Complex
Adelheid Wiemer-Kruel et al.
NEUROPEDIATRICS (2019)
Epilepsy in tuberous sclerosis complex: Findings from the TOSCA Study
Rima Nabbout et al.
EPILEPSIA OPEN (2019)
Symptomatic improvement using everolimus in infants with cardiac rhabdomyoma
Bhargavi Dhulipudi et al.
ANNALS OF PEDIATRIC CARDIOLOGY (2019)
Effect and Complications of Everolimus Use for Giant Cardiac Rhabdomyomas with Neonatal Tuberous Sclerosis
Yuka Shibata et al.
AJP REPORTS (2019)
Efficacy and safety of everolimus in patients younger than 12 months with congenital subependymal giant cell astrocytoma
Ichiro Kuki et al.
BRAIN & DEVELOPMENT (2018)
Everolimus dosing recommendations for tuberous sclerosis complex-associated refractory seizures
David N. Franz et al.
EPILEPSIA (2018)
Dramatic relapse of seizures after everolimus withdrawal
Alessia Mingarelli et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2018)
Short-term safety of mTOR inhibitors in infants and very young children with tuberous sclerosis complex (TSC): Multicentre clinical experience
Darcy A. Krueger et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2018)
mTOR dysregulation and tuberous sclerosis-related epilepsy
Paolo Curatolo et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2018)
Retinal astrocytoma regression in tuberous sclerosis patients treated with everolimus
Anat Bachar Zipori et al.
JOURNAL OF AAPOS (2018)
Effect of everolimus on skin lesions in patients treated for subependymal giant cell astrocytoma and renal angiomyolipoma: final 4-year results from the randomized EXIST-1 and EXIST-2 studies
D. N. Franz et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2018)
mTOR dysregulation and tuberous sclerosis-related epilepsy
Paolo Curatolo et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2018)
Sirolimus Gel Treatment vs Placebo for Facial Angiofibromas in Patients With Tuberous Sclerosis Complex A Randomized Clinical Trial
Mari Wataya-Kaneda et al.
JAMA DERMATOLOGY (2018)
Efficacy and Safety of Topical Rapamycin in Patients With Facial Angiofibromas Secondary to Tuberous Sclerosis Complex The TREATMENT Randomized Clinical Trial
Mary Kay Koenig et al.
JAMA DERMATOLOGY (2018)
Everolimus in infants with tuberous sclerosis complex-related West syndrome: First results from a single-center prospective observational study
Sharon Samueli et al.
EPILEPSIA (2018)
Everolimus for treatment-refractory seizures in TSC: Extension of a randomized controlled trial
David N. Franz et al.
NEUROLOGY-CLINICAL PRACTICE (2018)
Adjunctive everolimus for children and adolescents with treatment-refractory seizures associated with tuberous sclerosis complex: post-hoc analysis of the phase 3 EXIST-3 trial
Paolo Curatolo et al.
LANCET CHILD & ADOLESCENT HEALTH (2018)
Progress report on new antiepileptic drugs: A summary of the Thirteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIII)
Meir Bialer et al.
EPILEPSIA (2017)
Everolimus to treat aggressive retinal astrocytic hamartoma in tuberous sclerosis complex
Nambi Nallasamy et al.
JOURNAL OF AAPOS (2017)
Beneficial Effects of Everolimus on Autism and Attention-Deficit/Hyperactivity Disorder Symptoms in a Group of Patients with Tuberous Sclerosis Complex
Ayse Kilincaslan et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2017)
TuberOus SClerosis registry to increase disease Awareness (TOSCA) - baseline data on 2093 patients
John C. Kingswood et al.
ORPHANET JOURNAL OF RARE DISEASES (2017)
Management of everolimus-associated adverse events in patients with tuberous sclerosis complex: a practical guide
Mark Davies et al.
ORPHANET JOURNAL OF RARE DISEASES (2017)
Regression of Neonatal Cardiac Rhabdomyoma in Two Months Through Low-Dose Everolimus Therapy: A Report of Three Cases
Jeng-Sheng Chang et al.
PEDIATRIC CARDIOLOGY (2017)
Everolimus Alleviates Obstructive Hydrocephalus due to Subependymal Giant Cell Astrocytomas
Romina Moavero et al.
PEDIATRIC NEUROLOGY (2017)
Acute Management of Symptomatic Subependymal Giant Cell Astrocytoma With Everolimus
Monica S. Arroyo et al.
PEDIATRIC NEUROLOGY (2017)
Presurgical Administration of mTOR Inhibitors in Patients with Large Subependymal Giant Cell Astrocytoma Associated with Tuberous Sclerosis Complex
Tao Jiang et al.
WORLD NEUROSURGERY (2017)
Efficacy and Safety of Topical Sirolimus Therapy for Facial Angiofibromas in the Tuberous Sclerosis Complex A Randomized Clinical Trial
Mari Wataya-Kaneda et al.
JAMA DERMATOLOGY (2017)
Everolimus long-term use in patients with tuberous sclerosis complex: Four-year update of the EXIST-2 study
John J. Bissler et al.
PLOS ONE (2017)
Pooled analysis of menstrual irregularities from three major clinical studies evaluating everolimus for the treatment of tuberous sclerosis complex
Steven Sparagana et al.
PLOS ONE (2017)
Regression of massive cardiac rhabdomyoma on everolimus therapy
Steven G. Hoshal et al.
PEDIATRICS INTERNATIONAL (2016)
Everolimus-induced near-resolution of giant cardiac rhabdomyomas and large renal angiomyolipoma in a newborn with tuberous sclerosis complex
Massimo Colaneri et al.
CARDIOLOGY IN THE YOUNG (2016)
White matter disruption is associated with persistent seizures in tuberous sclerosis complex
Romina Moavero et al.
EPILEPSY & BEHAVIOR (2016)
Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study
Jacqueline A. French et al.
LANCET (2016)
Sirolimus for epilepsy in children with tuberous sclerosis complex: A randomized controlled trial
Iris E. Overwater et al.
NEUROLOGY (2016)
Long-term treatment of epilepsy with everolimus in tuberous sclerosis
Darcy A. Krueger et al.
NEUROLOGY (2016)
Long-Term Use of Everolimus in Patients with Tuberous Sclerosis Complex: Final Results from the EXIST-1 Study
David N. Franz et al.
PLOS ONE (2016)
Everolimus for Subependymal Giant Cell Astrocytoma: 5-Year Final Analysis
David N. Franz et al.
ANNALS OF NEUROLOGY (2015)
Oral Everolimus for Treatment of a Giant Left Ventricular Rhabdomyoma in a Neonate-Rapid Tumor Regression Documented by Real Time 3D Echocardiography
Robert Wagner et al.
ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES (2015)
Response to everolimus is seen in TSC-associated SEGAs and angiomyolipomas independent of mutation type and site in TSC1 and TSC2
David J. Kwiatkowski et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2015)
Neurological and neuropsychiatric aspects of tuberous sclerosis complex
Paolo Curatolo et al.
LANCET NEUROLOGY (2015)
Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complex
Jeffrey P. MacKeigan et al.
NEURO-ONCOLOGY (2015)
Mechanistic Target of Rapamycin (mTOR) in Tuberous Sclerosis Complex-Associated Epilepsy
Paolo Curatolo
PEDIATRIC NEUROLOGY (2015)
Use of mTOR Inhibitor Everolimus in Three Neonates for Treatment of Tumors Associated With Tuberous Sclerosis Complex
Isabelle Goyer et al.
PEDIATRIC NEUROLOGY (2015)
Prenatal diagnosis of giant cardiac rhabdomyoma in tuberous sclerosis complex: a new therapeutic option with everolimus
E. Mlczoch et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2015)
Mammalian Target of Rapamycin Inhibitors and Life-Threatening Conditions in Tuberous Sclerosis Complex
Romina Moavero et al.
SEMINARS IN PEDIATRIC NEUROLOGY (2015)
Everolimus treatment of a newborn with rhabdomyoma causing severe arrhythmia
Funda Oztunc et al.
CARDIOLOGY IN THE YOUNG (2015)
Everolimus Treatment for an Early Infantile Subependymal Giant Cell Astrocytoma With Tuberous Sclerosis Complex
Shinobu Fukumura et al.
JOURNAL OF CHILD NEUROLOGY (2015)
Regression of Symptomatic Multiple Cardiac Rhabdomyomas Associated with Tuberous Sclerosis Complex in a Newborn Receiving Everolimus
Vehbi Dogan et al.
JOURNAL OF TROPICAL PEDIATRICS (2015)
Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study
David Neal Franz et al.
LANCET ONCOLOGY (2014)
Fetal Brain Lesions in Tuberous Sclerosis Complex: TORC1 Activation and Inflammation
Avanita S. Prabowo et al.
BRAIN PATHOLOGY (2013)
Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): Clinical recommendations
Sergiusz Jozwiak et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2013)
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
David Neal Franz et al.
LANCET (2013)
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
John J. Bissler et al.
LANCET (2013)
Cardiac Rhabdomyomas Associated with Tuberous Sclerosis Complex in 11 Children: Presentation to Outcome
Abdullah Kocabas et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2013)
Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
Hope Northrup et al.
PEDIATRIC NEUROLOGY (2013)
Loss of White Matter Microstructural Integrity Is Associated with Adverse Neurological Outcome in Tuberous Sclerosis Complex
Jurriaan M. Peters et al.
ACADEMIC RADIOLOGY (2012)
Everolimus: A Challenging Drug in the Treatment of Multifocal Inoperable Cardiac Rhabdomyoma
Haci Ahmet Demir et al.
PEDIATRICS (2012)
Long-term neurological outcome in children with early-onset epilepsy associated with tuberous sclerosis
Raffaella Cusmai et al.
EPILEPSY & BEHAVIOR (2011)
Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis
Francis X. McCormack et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Regression of a Cardiac Rhabdomyoma in a Patient Receiving Everolimus
Dana Tiberio et al.
PEDIATRICS (2011)
Rapamycin as an alternative to surgical treatment of subependymal giant cell astrocytomas in a patient with tuberous sclerosis complex Case report
Ala Birca et al.
JOURNAL OF NEUROSURGERY-PEDIATRICS (2010)
Regression of Subependymal Giant Cell Astrocytoma With Rapamycin in Tuberous Sclerosis Complex
Mary Kay Koenig et al.
JOURNAL OF CHILD NEUROLOGY (2008)
Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosis
D. Mark Davies et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis
John J. Bissler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors
S. K. Rakowski et al.
KIDNEY INTERNATIONAL (2006)
Rapamycin causes regression of astrocytomas in tuberous sclerosis complex
DN Franz et al.
ANNALS OF NEUROLOGY (2006)
Increased brain apparent diffusion coefficient in tuberous sclerosis
FG Garaci et al.
RADIOLOGY (2004)
Usefulness of diagnostic criteria of tuberous sclerosis complex in pediatric patients
S Józwiak et al.
JOURNAL OF CHILD NEUROLOGY (2000)
High frequency of pulmonary lymphangioleiomyomatosis in women with tuberous sclerosis complex
LC Costello et al.
MAYO CLINIC PROCEEDINGS (2000)
分享论文
